Aciphex: Advanced Acid Control for GERD Relief
Aciphex
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.93 | $56.00 (0%) | 🛒 Add to cart |
| 90 | $0.87 | $84.00 $78.00 (7%) | 🛒 Add to cart |
| 120 | $0.83 | $112.00 $100.00 (11%) | 🛒 Add to cart |
| 180 | $0.79 | $168.00 $143.00 (15%) | 🛒 Add to cart |
| 270 | $0.77 | $252.00 $209.00 (17%) | 🛒 Add to cart |
| 360 | $0.76
Best per pill | $336.00 $274.00 (18%) | 🛒 Add to cart |
Synonyms | |||
Aciphex (rabeprazole sodium) is a proton pump inhibitor (PPI) designed for the effective, long-term management of gastroesophageal reflux disease (GERD) and associated conditions. By targeting the proton pumps in the stomach lining, it provides sustained reduction of gastric acid production, facilitating mucosal healing and symptom relief. This prescription medication is formulated for patients requiring consistent acid suppression, offering a clinically proven option for both short-term symptomatic control and maintenance therapy in moderate to severe cases.
Features
- Active ingredient: Rabeprazole sodium
- Delayed-release tablet formulation
- Available in 20 mg strength
- Designed for once-daily dosing
- Enteric coating to protect against gastric acid degradation
- Demonstrated stability across various pH conditions
Benefits
- Provides rapid and sustained relief from heartburn and acid regurgitation
- Promotes healing of erosive esophagitis
- Reduces risk of GERD symptom recurrence
- Allows for improved sleep and quality of life by controlling nighttime symptoms
- Minimizes acid-related damage to esophageal tissue
- Supports long-term management of hypersecretory conditions
Common use
Aciphex is primarily indicated for the treatment of gastroesophageal reflux disease (GERD), including healing and maintenance of erosive esophagitis. It is also prescribed for the treatment of duodenal ulcers, pathological hypersecretory conditions such as Zollinger-Ellison syndrome, and in combination with antibiotics for Helicobacter pylori eradication to reduce the risk of duodenal ulcer recurrence.
Dosage and direction
The recommended adult dosage for GERD and healing of erosive esophagitis is 20 mg once daily for 4 to 8 weeks. Maintenance therapy for healed erosive esophagitis is 20 mg once daily. For H. pylori eradication, Aciphex 20 mg is taken twice daily alongside prescribed antibiotics for 7 days. Tablets should be swallowed whole, with or without food, and should not be crushed, split, or chewed. Dosage adjustments may be necessary for patients with severe hepatic impairment.
Precautions
Patients should be advised that Aciphex may mask symptoms of gastric malignancy; appropriate diagnostic evaluations should be conducted if alarm features (e.g., unintended weight loss, recurrent vomiting, dysphagia) are present. Long-term use (particularly beyond one year) may be associated with an increased risk of Clostridium difficile-associated diarrhea, hypomagnesemia, and bone fractures. Periodic magnesium monitoring is recommended in patients expected to be on prolonged therapy or taking digoxin or drugs that may cause hypomagnesemia. Vitamin B12 deficiency may occur with long-term use due to decreased gastric acid.
Contraindications
Aciphex is contraindicated in patients with known hypersensitivity to rabeprazole, substituted benzimidazoles, or any component of the formulation. Concomitant use with rilpivirine-containing products is contraindicated due to the potential for decreased antiviral efficacy.
Possible side effect
Common adverse reactions (≥2% incidence) include headache, diarrhea, nausea, vomiting, abdominal pain, flatulence, and pharyngitis. Less frequently reported effects include rash, dizziness, insomnia, and elevated liver enzymes. Serious side effects may include severe cutaneous adverse reactions (e.g., Stevens-Johnson syndrome), acute interstitial nephritis, fundic gland polyps (with long-term use), and lupus erythematosus. Patients should report any persistent or severe symptoms to their healthcare provider.
Drug interaction
Aciphex may alter the absorption of drugs requiring gastric acid for bioavailability, such as ketoconazole, iron salts, and digoxin. It may increase exposure to methotrexate. Concomitant use with warfarin may require increased monitoring of INR due to potential interactions. Rabeprazole is metabolized by CYP2C19 and CYP3A4; caution is advised when coadministering with strong inducers or inhibitors of these enzymes. Avoid concomitant use with atazanavir and nelfinavir due to reduced antiviral efficacy.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Patients should not take a double dose to make up for a missed one.
Overdose
Limited data exist on Aciphex overdose. Reported doses of up to 80 mg have been tolerated without incident. In case of suspected overdose, supportive and symptomatic treatment is recommended. Rabeprazole is not removed by hemodialysis. Medical attention should be sought immediately if overdose is suspected.
Storage
Store at room temperature (20°C to 25°C/68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Keep in the original container with the lid tightly closed to protect from moisture. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging.
Disclaimer
This information is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Do not disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
Clinical studies and post-marketing surveillance have demonstrated Aciphex to be effective and well-tolerated in the majority of patients. In controlled trials, 84% of patients with erosive GERD experienced complete healing after 8 weeks of therapy. Many users report significant improvement in quality of life, reduced nighttime symptoms, and reliable 24-hour acid control. Some patients note the convenience of once-daily dosing and the minimal side effect profile compared to other acid-suppressing agents. As with all medications, individual experiences may vary based on underlying conditions, adherence, and physiological factors.